The clinical manifestations of Down syndrome are numerous and can present in any body system. The most significant include intellectual impairment, short stature, heart disease, digestive disease, orthopedic abnormalities 3 and congenital vascular malformation. 5 Heart disease is, without a doubt, the main factor contributing to a favorable or unfavorable cause in these patients.
In patient with DS, pulmonary arterial hypertension (PAH) has been suggested to develop earlier and to have mere violent course. Eisenmenger's syndrome carries a high risk of morbidity in a relatively young patient population and has limited therapeutic option. 4 The main causes of death in Down syndrome with heart disease are heart failure, sepsis and pulmonary hypertension. This last process appears earlier in patients with atrioventricular septal defect (AVSD) and results in a reduction in survival of up to 58%. 3 The incidence of upper airway obstruction in Down syndrome is to be 30-50%. 4 Down syndrome individuals have a higher rate of infections, especially respiratory tract infections (RTI) which is 50 times more common compared to the general population. Bronchopneumonia is a common cause of death with mortality rate 124 times that of the general population. 4 We, here in, discuss two patients with this syndrome having ventricular septal defect with severe respiratory tract infections. Treatment : The diagnosis of the patient was Down syndrome with a VSD. The VSD was closed with PTFE patch. The patient was discharged after 7 days without any complication. and postoperative echocardiography showed normal biventricular function without residual VSD.
Case 1

Case 2
Clinical presentation: R is a baby with Down Syndrome who is almost 5 months old, had been referred from Darussalam, Brunei to Institute Jantung Negara (IJN), Malaysia(MY) as a diagnosis of Down syndrome with large peri membranous VSD with inlet extension, pulmonary hypertension and transient Myeloproliferative disorder. She was born term, the 4 th child on non-consanguineous parents. Her platelet counts from birth had been persistently low (30-60 thousand) and blast cells consistently found on peripheral blood smear. Her hematological abnormalities (low platelet counts, rising white cell counts with peripheral blast cells and falling haemoglobin levels) remained during the first 4 months of life. Fortunately, this has resolved over the past few weeks.
Fig.-2: Echocardiography showing perimembranous VSD
Discussion:
First described in 1866, Down syndrome is a condition characterized by Trisomy of chromosome 21. Among all cases 95% are primary trisomy and 5% are translocation and mosaic forms (3% and 2% respectively) 3 . The frequency of presentation is one in 650 live births. Frequency in the general population is about 1%. Cardiac malformation is the main cause of mortality in the first 2 years of life. 3 The prevalence of Down syndrome increased from 1.3 to 2.5 per 1000 live births showed in 20 years study 6 . Congenital heart defects reduce survival in Down syndrome patients by 72%. ASD and VSD in the early phases are associated with better survival rates than AVSD. 3 However in last 20 years study showed survival in infants with Down syndrome with normal heart increased from 93 to 97% and in those with cardiovascular malformation from 78 to 90%. 6 In Guatemala, a series showed 189 patients (54%) had congenital cardiac defect among 349 patients of Down syndrome, in 189 patient, 52 were VSD (27.5%). 7 Other series in Mexico showed among 275 children, 160 had congenital heart disease (58%), the most frequent cardiopathies were ASD (58%), VSD and PDA (90%). Twenty five patients (15.7%) died from sepsis and cardiogenic shock. 3 Two of our patients had respiratory tract infection and was controlled vigorously with antibiotics, physiotherapy and nebulization according to treatment protocol.
The children with congenital heart disease and Down syndrome have an unusually high pulmonary vascular resistance and a propensity for early development of damage 4 to the pulmonary vascular bed. The first six months of life considered the best time for definite repair because of the progression of pulmonary vascular disease and atrioventricular valve regurtitation. Some patients with Down syndrome undergo successful repair even in their second and others die of pulmonary hypertensive crisis even in their first six months of life. 4 Vascular malformation of brain with Down syndrome has not been reported in the literature. Rajniti Prasad reported a child with Down syndrome with associated arterio venous malformation in the brain, who developed stroke and treated successfully. 5 It always is important to obtain routine chromosomal study (Karyotype) for a child who has Down syndrome because it is critical for accurate recurrence risk counseling to separate the 95% of children who have Trisomy 21 due to non disjunction from the 2% to 3% who have a Robertsonian translocation involving chromosome 21, which can be inherited from a parent. 1
Conclusion:
The survival and quality of life have been improving in patients with Down syndrome due to early repair of congenital heart defects to halt sepsis, the prognosis of PAH and improvement in critical care facilities and vasodilator use.
